CIK 0001604464 · Non-accelerated filer<br>Smaller reporting company
Atara Biotherapeutics, Inc.
Sign in to watch- Ticker
- ATRA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 460920988
- Phone
- 805-623-4211
- Business address
- 1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA, 91320
- Open-market buys, last 90 days
- $999,994
- in 1 filing
- Open-market sales, last 90 days
- $40,883
- in 1 filing
Net +$959,111. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-08-16 | Hyllengren Eric J SVP, CFO | Sale | −1,778 | $1.65 | $3K | 217,956 |
| 2023-08-16 | Murugan Amar EVP, Chief Legal Officer | Sale | −5,050 | $1.65 | $8K | 269,013 |
| 2023-08-16 | Murugan Amar EVP, Chief Legal Officer | Sale | −3,622 | $1.65 | $6K | 265,391 |
| 2023-08-16 | Touchon Pascal President and CEO | Sale | −21,432 | $1.65 | $35K | 685,239 |
| 2023-08-16 | Touchon Pascal President and CEO | Sale | −9,334 | $1.65 | $15K | 675,905 |
| 2023-08-16 | Nguyen AnhCo EVP, Chief Sci. & Tech Officer | Sale | −5,849 | $1.65 | $10K | 295,276 |
| 2023-08-16 | Nguyen AnhCo EVP, Chief Sci. & Tech Officer | Sale | −9,277 | $1.65 | $15K | 285,999 |
| 2023-08-16 | Joshi Manher EVP, Chief Medical Officer | Sale | −3,202 | $1.65 | $5K | 187,344 |
| 2023-08-16 | Joshi Manher EVP, Chief Medical Officer | Sale | −3,773 | $1.65 | $6K | 183,571 |
| 2023-08-16 | Henrich Jill EVP, Global Head RA & Quality | Sale | −2,788 | $1.65 | $5K | 108,249 |
| 2023-08-16 | Henrich Jill EVP, Global Head RA & Quality | Sale | −558 | $1.65 | $923 | 107,691 |
| 2023-06-27 | Touchon Pascal President and CEO | Sale | −14,291 | $1.66 | $24K | 706,671 |
| 2023-05-31 | SEIDENBERG BETH C Director | Grant or award | +57,000 | 115,689 | ||
| 2023-05-31 | SEIDENBERG BETH C Director | Grant or award · Non-Qualified Stock Option (Right to Buy) | +79,500 | 79,500 | ||
| 2023-05-31 | Roncarolo Maria Grazia Director | Grant or award | +57,000 | 88,500 | ||
| 2023-05-31 | Roncarolo Maria Grazia Director | Grant or award · Non-Qualified Stock Option (Right to Buy) | +79,500 | 79,500 | ||
| 2023-05-31 | Gallagher Carol Giltner Director | Grant or award | +57,000 | 189,418 | ||
| 2023-05-31 | Gallagher Carol Giltner Director | Grant or award · Non-Qualified Stock Option (Right to Buy) | +79,500 | 79,500 | ||
| 2023-05-31 | Fust Matthew K Director | Grant or award | +57,000 | 109,000 | ||
| 2023-05-31 | Fust Matthew K Director | Grant or award · Non-Qualified Stock Option (Right to Buy) | +79,500 | 79,500 |
Page 7 of 17 · 334 trades